Redsense Medical to focus on core growth areas, discontinuing trading on OTCQX

Redsense Medical AB has decided not to renew its agreement with OTC Markets Group after the current term, which ends on December 31, 2024. Redsense Medical began trading on the OTCQX platform on September 29, 2023 under the symbol “RDSNF”.

"While our time on the OTCQX platform has provided valuable insights, we have chosen to refocus our efforts toward key priotities that will better support our growth. Our primary goal is to accelarate profitability, and we believe the most effective use of our resources will be to drive sales growth and enhance communication with our strong and engaged shareholder base, which has steadily grown since our listing in 2015”, says Sebastien Bollue, CEO of Redsense Medical AB.